- Correction
- Open access
- Published:
Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
Journal for ImmunoTherapy of Cancer volume 7, Article number: 94 (2019)
The Original Article was published on 14 March 2019
Correction to: J Immunother Cancer 2019 7:75
https://doi.org/10.1186/s40425-019-0525-0
Following publication of the original article [1], the author reported two errors in the authors affiliations:
1. Dr. Song Cheol Kim should be affiliated to Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery,University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea;
2. Dr. Eun Sung Jun should be affiliated to Department of Convergence Medicine, Asan Institute for Life Sciences, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Republic of Korea and to Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery,University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea;
Reference
Yao et al. Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. Journal for ImmunoTherapy of Cancer. 2019;7:75. https://doi.org/10.1186/s40425-019-0525-0.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Yao, HP., Feng, L., Suthe, S.R. et al. Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy. j. immunotherapy cancer 7, 94 (2019). https://doi.org/10.1186/s40425-019-0571-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40425-019-0571-7